4.3 Article

Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43

Journal

JOURNAL OF VETERINARY SCIENCE
Volume 11, Issue 2, Pages 165-167

Publisher

KOREAN SOC VETERINARY SCIENCE
DOI: 10.4142/jvs.2010.11.2.165

Keywords

cross-reactivity; HCoV 229E; HCoV OC43; recombinant nucleocapsid protein; SARS

Funding

  1. Korea Food and Drug Administration
  2. Korea Research Foundation [KRF-005-E00077]
  3. BK21 Program for Veterinary Science

Ask authors/readers for more resources

Severe acute respiratory syndrome (SARS) is a life-threatening disease for which accurate diagnosis is essential. Although many tools have been developed for the diagnosis of SARS, false-positive reactions in negative sera may occur because of cross-reactivity with other coronaviruses. We have raised polyclonal and monoclonal antibodies (Abs) using a recombinant form of the SARS virus nucleocapsid protein. Cross-reactivity of these anti-SARS Abs against human coronavirus (HCoV) 229E and HCoV OC43 were determined by Western blotting. The Abs produced reacted with recombinant SARS virus nucleocapsid protein, but not with HCoV 229E or HCoV OC43.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available